Increased expression of UDP-galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants
- PMID: 11389099
Increased expression of UDP-galactose transporter messenger RNA in human colon cancer tissues and its implication in synthesis of Thomsen-Friedenreich antigen and sialyl Lewis A/X determinants
Abstract
A series of human nucleotide sugar transporters of the Golgi apparatus was recently cloned, including the transporters for UDP-galactose (UDP-Gal), UDP-N-acetylglucosamine (UDP-GlcNAc) and CMP-sialic acid (CMP-SA). We have examined the mRNA expression of these three transporters in human colon cancer tissues by reverse transcription-PCR analysis and compared it with that in nonmalignant colonic mucosa prepared from the same patients. The amount of mRNA for UDP-Gal transporter was significantly increased in colon cancer tissues compared with nonmalignant mucosa tissues (P = 0.035; n = 20). The increase was more prominent in patients with advanced colorectal cancer of Dukes' stages C and D, in which the amount of UDP-Gal transporter mRNA in cancer tissues showed on average about a 3.6-fold increase over the paired nonmalignant mucosa (statistically significant at P = 0.004; n = 14). The mRNA content of the other two transporters showed no significant difference between the paired cancer and normal tissues. When UDP-Gal transporter cDNA was stably transfected to cultured human colon cancer cells, the expression of Thomsen-Friedenreich (TF) antigen and of sialyl Lewis A (NeuAcalpha2-->3Galbeta1-->3[Fucalpha1-->4]GlcNAcbeta1-->R) and sialyl Lewis X (NeuAcalpha2-->3Galbeta1-->4[Fucalpha1-->3]GlcNAcbeta1-->R) determinants was significantly induced on transfectant cells, which resulted in markedly enhanced cell adhesion to vascular E-selectin. These findings suggest that the increase of UDP-Gal transporter mRNA is involved in the enhanced expression of cancer-associated carbohydrate determinants such as TF and sialyl Lewis A/X antigens in colon cancers.
Similar articles
-
Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers.Cancer Res. 2004 Jul 1;64(13):4498-505. doi: 10.1158/0008-5472.CAN-03-3614. Cancer Res. 2004. PMID: 15231659
-
Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells.Cancer Res. 2010 May 15;70(10):4064-73. doi: 10.1158/0008-5472.CAN-09-2383. Epub 2010 May 11. Cancer Res. 2010. PMID: 20460514
-
Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-->6GalNAcalpha core structure as a tumor-associated antigen.Biochem Biophys Res Commun. 1998 Jun 18;247(2):514-7. doi: 10.1006/bbrc.1998.8824. Biochem Biophys Res Commun. 1998. PMID: 9642161
-
[Structures, synthesis and functions of sialyl Le(a)/sialyl Le(x) antigens].Nihon Rinsho. 1995 Jul;53(7):1729-34. Nihon Rinsho. 1995. PMID: 7630014 Review. Japanese.
-
Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression.Chang Gung Med J. 2007 May-Jun;30(3):189-209. Chang Gung Med J. 2007. PMID: 17760270 Review.
Cited by
-
Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.Chem Rev. 2015 Sep 23;115(18):10261-306. doi: 10.1021/acs.chemrev.5b00244. Epub 2015 Aug 28. Chem Rev. 2015. PMID: 26317756 Free PMC article. Review.
-
Glycosylation: mechanisms, biological functions and clinical implications.Signal Transduct Target Ther. 2024 Aug 5;9(1):194. doi: 10.1038/s41392-024-01886-1. Signal Transduct Target Ther. 2024. PMID: 39098853 Free PMC article. Review.
-
Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in Current Management.Medeni Med J. 2022 Jun 23;37(2):194-202. doi: 10.4274/MMJ.galenos.2022.63139. Medeni Med J. 2022. PMID: 35735183 Free PMC article.
-
Comparative analysis of involvement of UGT1 and UGT2 splice variants of UDP-galactose transporter in glycosylation of macromolecules in MDCK and CHO cell lines.Glycoconj J. 2011 Oct;28(7):481-92. doi: 10.1007/s10719-011-9348-z. Epub 2011 Sep 6. Glycoconj J. 2011. PMID: 21894462 Free PMC article.
-
Glycosylation in cancer: mechanisms and clinical implications.Nat Rev Cancer. 2015 Sep;15(9):540-55. doi: 10.1038/nrc3982. Epub 2015 Aug 20. Nat Rev Cancer. 2015. PMID: 26289314 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous